Oral contraceptives and endocrine changes.
Journal: 1972/October - Bulletin of the World Health Organization
ISSN: 0042-9686
PUBMED: 4538188
Abstract:
In groups of women taking oral contraceptives and in control groups of women, the serum levels of cortisol, protein-bound iodine, and total thyroxine were measured together with the T(3) binding index. The daily excretion in the urine of free cortisol, 17-hydroxycorticosteroids, 17-ketosteroids, pregnanediol, pregnanetriol, total oestrogens, total catecholamines, and 4-hydroxy-3-methoxymandelic acid was also assayed. The frequency distribution of the values obtained indicates that oral contraceptives have a marked influence on the endocrine environment. The smallest deviations were observed in urinary excretion of total catecholamines and of 4-hydroxy-3-methoxymandelic acid. In some individuals the hormone assays were continued throughout the menstrual cycle. The morning and afternoon levels of serum cortisol tended to increase during the period when the oral contraceptive was being taken.
Relations:
Content
Citations
(2)
References
(12)
Diseases
(1)
Drugs
(2)
Chemicals
(8)
Organisms
(1)
Anatomy
(1)
Similar articles
Articles by the same authors
Discussion board
Bull World Health Organ 46(4): 443-450

Oral contraceptives and endocrine changes<sup><a href="#fn1" rid="fn1" class=" fn">*</a></sup>

Abstract

In groups of women taking oral contraceptives and in control groups of women, the serum levels of cortisol, protein-bound iodine, and total thyroxine were measured together with the T3 binding index. The daily excretion in the urine of free cortisol, 17-hydroxycorticosteroids, 17-ketosteroids, pregnanediol, pregnanetriol, total oestrogens, total catecholamines, and 4-hydroxy-3-methoxymandelic acid was also assayed. The frequency distribution of the values obtained indicates that oral contraceptives have a marked influence on the endocrine environment. The smallest deviations were observed in urinary excretion of total catecholamines and of 4-hydroxy-3-methoxymandelic acid. In some individuals the hormone assays were continued throughout the menstrual cycle. The morning and afternoon levels of serum cortisol tended to increase during the period when the oral contraceptive was being taken.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bradley EM, Waterhouse C. Effect of estrogen administration on extravascular cortisol. J Clin Endocrinol Metab. 1966 Jul;26(7):705–714. [PubMed] [Google Scholar]
  • Burke CW. The effect of oral contraceptives on cortisol metabolism. J Clin Pathol Suppl (Assoc Clin Pathol) 1969;3:11–18.[PMC free article][Google Scholar]
  • Elgee NJ. Medical aspects of oral contraceptives. Ann Intern Med. 1970 Mar;72(3):409–418. [PubMed] [Google Scholar]
  • ITTRICH G. [Studies on the extraction of red Kober dyes by organic solvents for the determination of urinary estrogens]. Acta Endocrinol (Copenh) 1960 Sep;35:34–48. [PubMed] [Google Scholar]
  • Kay CR. British experience of the pill. Can Fam Physician. 1970 May;16(5):57–61.[PMC free article] [PubMed] [Google Scholar]
  • LAYNE DS, MEYER CJ, VAISHWANAR PS, PINCUS G. The secretion and metabolism of cortisol and aldosterone in normal and in steroid-treated women. J Clin Endocrinol Metab. 1962 Feb;22:107–118. [PubMed] [Google Scholar]
  • Lucis OJ, Cummings GT, Matthews S, Burry C. Laboratory observations of assays of serum thyroxine and protein-bound iodine. J Nucl Med. 1969 Apr;10(4):160–163. [PubMed] [Google Scholar]
  • Mishell DR, Jr, Colodny SZ, Swanson LA. The effect of an oral contraceptive on tests of thyroid function. Fertil Steril. 1969 Mar-Apr;20(2):335–339. [PubMed] [Google Scholar]
  • Murphy BE. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. J Clin Endocrinol Metab. 1967 Jul;27(7):973–990. [PubMed] [Google Scholar]
  • SILBER RH, PORTER CC. The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma. J Biol Chem. 1954 Oct;210(2):923–932. [PubMed] [Google Scholar]
  • von EULER U, LISHAJKO F. The estimation of catechol amines in urine. Acta Physiol Scand. 1959 Mar 31;45:122–132. [PubMed] [Google Scholar]
  • Weitzman ED, Schaumburg H, Fishbein W. Plasma 17-hydroxycorticosteroid levels during sleep in man. J Clin Endocrinol Metab. 1966 Feb;26(2):121–127. [PubMed] [Google Scholar]
  • ZIMMERMANN W, PONTIUS D. Zur Mikrobestimmung der neutralen 17-Ketosteroide. Hoppe Seylers Z Physiol Chem. 1954;297(3-6):157–163. [PubMed] [Google Scholar]
Part of the information contained in this paper was reported at a meeting of the Canadian Society for Clinical Investigation, in January 1971.
Abstract
In groups of women taking oral contraceptives and in control groups of women, the serum levels of cortisol, protein-bound iodine, and total thyroxine were measured together with the T3 binding index. The daily excretion in the urine of free cortisol, 17-hydroxycorticosteroids, 17-ketosteroids, pregnanediol, pregnanetriol, total oestrogens, total catecholamines, and 4-hydroxy-3-methoxymandelic acid was also assayed. The frequency distribution of the values obtained indicates that oral contraceptives have a marked influence on the endocrine environment. The smallest deviations were observed in urinary excretion of total catecholamines and of 4-hydroxy-3-methoxymandelic acid. In some individuals the hormone assays were continued throughout the menstrual cycle. The morning and afternoon levels of serum cortisol tended to increase during the period when the oral contraceptive was being taken.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.